Ibuprofen is a medication commonly used to reduce pain and inflammation, but a new study suggests its benefits do not stop there. Researchers have found that the drug may also reduce the risk of death from lung cancer among former and current smokers.
Researchers analyzed the data of 10,735 adults who were part of the Third National Health and Nutrition Examination Survey (NHANES III), enrolling between 1988-1994.
Overall, the team found that former or current smokers who regularly used ibuprofen were 48% less likely to die from lung cancer than those who did not use the drug.
The link between lung cancer death risk and the use of aspirin – another common NSAID – was not statistically significant, the authors report.
- Disorders & Diseases
- Public Health
- Products & Treatment
- Department Management
- Edition Archive